“An active focus on business and product development is a prerequisite for AcuCort’s sustainable growth journey.”
The overall goal is to develop and commercialize new innovative drugs that offer both clinical relevance and patient benefits.
AcuCort is an innovative biotechnology company that identifies, develops and commercializes smart drugs that meet the patient’s needs for a user-friendly and effective treatments.
Potential drug candidates are based on existing and well-documented substances in indication areas where there is a great medical need and commercial interest in new and innovative drugs that bring benefits, such as simple administration. The approved drug is commercialized in partnership with a global network of licensees and distributors.
AcuCort’s strong entrepreneurship and drive, together with the company’s good collaborative skills with a broad networks of external expertise and subcontractors, create good conditions for business and product development.